
With a mifepristone safety review due by March and Senate control shifting in January, the FDA faces an extended stretch without a permanent leader.
Pharmacy Times® invites you to join us and experts in pharmacy to gain insight into the value pharmacists provide in treating patients throughout the pandemic.
Pharmacy Times® invites you to join us and experts in pharmacy to gain insight into the value pharmacists provide in treating patients throughout the coronavirus disease 2019 (COVID-19) pandemic. The Pharmacy Times® webinar “The Value of the Pharmacist in Treating COVID-19” will be held Tuesday, April 28 at 12 pm EDT.
Click to register for this complimentary webinar:
Join expert faculty members as they explore:





